Mark Wilkowski, PA
Emergency Medical Services · Cheektowaga, NYNPI 1164479150
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Among emergency medical services clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$329
- AstraZeneca$239
- Exact Sciences$101
- GSK$91
- Boston Scientific$74
- Lilly USA, LLC$70
- plus $537 from 15 others
What the payments were for
- Food & beverage$1,442100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $329 |
| AstraZeneca | 14 | $239 |
| Exact Sciences | 5 | $101 |
| GSK | 5 | $91 |
| Boston Scientific | 2 | $74 |
| Lilly USA, LLC | 4 | $70 |
| Merck | 3 | $62 |
| Amgen | 3 | $53 |
| Shield Therapeutics Inc | 3 | $50 |
| Indivior Inc. | 2 | $46 |
| Insulet Corporation | 2 | $44 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| Eisai Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $37 |
| Corcept Therapeutics | 2 | $35 |
| Tandem Diabetes Care, Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Pfizer | 1 | $18 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $13 |
How this compares
$1,442 in reported general payments places this provider in the 90th percentile of 74 emergency medical services providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $20,893 |
| TrulicityDulaglutide | 12 | $13,655 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,491 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,747 |
| Naproxen | 23 | $1,534 |
| Gabapentin | 64 | $1,482 |
| Atorvastatin Calcium | 93 | $1,191 |
| Rosuvastatin Calcium | 67 | $618 |
| Pantoprazole Sodium | 28 | $609 |
| Levothyroxine Sodium | 33 | $569 |
| Omeprazole | 52 | $506 |
| Famotidine | 33 | $420 |
| Metoprolol Succinate | 30 | $383 |
| Duloxetine Hcl | 27 | $371 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $20,89313 claims |
| Lilly USA, LLCTrulicity | $70 | $13,65512 claims |
| AstraZenecaBreztri Aerosphere | $239 | $6,49111 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $42 | $56933 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 74 emergency medical services providers in New York.
Other emergency medical services in Cheektowaga
- Ronald SomogyiKenmore$14K
- Yvette CalderonBronx$11K
- Ugo EzenkweleBrooklyn$4K
- Daniel LopezCortlandt Manor$4K
- Kenneth HirschPort Jefferson$2K
- Steven BradleyLewiston$2K
- Reine JamesWest Islip$1K
- Corey WeinerBrooklyn$1K
- Yelena GekhtBrooklyn$914
- David ChengFlushing$692
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.